Skip to main content

Find Clinical Trials

Home
Conditions
Drug-Drug Interaction (DDI)

Clinical trial condition

Drug-Drug Interaction (DDI)

Explore clinical trials studying Drug-Drug Interaction (DDI). Study availability and eligibility vary by location and protocol.

9 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Drug-Drug Interaction (DDI) trial results

Recruiting

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

NCT05176483

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +48 more
Locations: Exelixis Clinical Site #67 Phoenix, Arizona, United States

Exelixis Clinical Site #1 Tucson, Arizona, United States

Exelixis Clinical Site #123 Palo Alto, California, United States

Exelixis Clinical Site #59 Santa Barbara, California, United States

View all 122 locations

View Trial Details

Recruiting

Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination

NCT06733675

Conditions: Drug-Drug Interaction (DDI), FDC, Healthy Volunteer, +2 more
Locations: ICON, Clinical Research Phase I Unit Lenexa, Kansas, United States

View Trial Details

Not yet recruiting

A Drug-Drug Interaction Study Between NTQ5082 Capsules and Midazolam Oral Solutio

NCT07745439

Conditions: Drug-Drug Interaction (DDI), Healthy Volunteers
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men

NCT02138799

Conditions: Drug-Drug Interaction (DDI), Healthy Subjects, Pharmacokinetics of Enzalutamide
Locations: Parexel International GmbH Berlin, Germany

View Trial Details

Completed

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects

NCT02169713

Conditions: Drug-Drug Interaction (DDI), Healthy Subjects, Pharmacokinetics
Locations: Parexel International GmbH Berlin, Germany

View Trial Details

Completed

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects

NCT02127034

Conditions: Drug-Drug Interaction (DDI), Healthy Subjects, Pharmacokinetics
Locations: Parexel International GmbH Berlin, Germany

View Trial Details

Completed

A Study to Evaluate Whether Verapamil Has an Effect on the Uptake and Elimination of Solifenacin and Tamsulosin When Administered in a Combination Tablet

NCT01943487

Conditions: Drug-Drug Interaction (DDI), Healthy Subjects
Locations: SGS Aster Paris, France

View Trial Details

Completed

A Study to Assess the Effects of Multiple Doses of Fidaxomicin on a Single Dose of Rosuvastatin in Healthy Male Subjects

NCT02083627

Conditions: Drug-Drug Interaction (DDI), Healthy Subjects, Intestinal Absorption, +2 more
Locations: Parexel GmbH Berlin, Germany

View Trial Details

Completed

A Study to Assess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the Effects of Multiple Doses of ASP3652 on a Single Dose of Repaglinide in the Body of Healthy Subjects

NCT01797198

Conditions: Drug-Drug Interaction (DDI), Healthy Subjects
Locations: PAREXEL Early Phase Clinical Unit Harrow, United Kingdom

View Trial Details